FDA official logo
GSRS logoPFDA official logo

OZURIFTAMAB VEDOTIN

UNII:BPM6YN0KLI
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:OZURIFTAMAB VEDOTIN
GSRS Full Record:
BPM6YN0KLI
i

  • 2460400-11-5
  • BA-302 CONJUGATED TO MONOMETHYL AURISTATIN E
  • BA-3021
  • BA3021
  • CAB-ROR2-ADC (BA-3021)
  • IMMUNOGLOBULIN G1 (DE-452-LYSINE), ANTI-(HUMAN TYROSINE KINASE RECEPTOR ROR2) (HUMAN-MUS MUSCULUS MONOCLONAL BA302 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BA302 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
  • OZURIFTAMAB VEDOTIN [USAN]
  • Ozuriftamab vedotin [WHO-DD]
  • ozuriftamab vedotin [INN]




UNII - BPM6YN0KLI | UNII Search Service